These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1168 related items for PubMed ID: 23042656

  • 1. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M, Ma S.
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [Abstract] [Full Text] [Related]

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Opportunities and challenges of using five-membered ring compounds as promising antitubercular agents.
    Yan M, Xu L, Wang Y, Wan J, Liu T, Liu W, Wan Y, Zhang B, Wang R, Li Q.
    Drug Dev Res; 2020 Jun; 81(4):402-418. PubMed ID: 31904877
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.
    Rivers EC, Mancera RL.
    Drug Discov Today; 2008 Dec; 13(23-24):1090-8. PubMed ID: 18840542
    [Abstract] [Full Text] [Related]

  • 7. SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
    Poce G, Cocozza M, Consalvi S, Biava M.
    Eur J Med Chem; 2014 Oct 30; 86():335-51. PubMed ID: 25173852
    [Abstract] [Full Text] [Related]

  • 8. New tuberculosis drugs on the horizon.
    Cole ST, Riccardi G.
    Curr Opin Microbiol; 2011 Oct 30; 14(5):570-6. PubMed ID: 21821466
    [Abstract] [Full Text] [Related]

  • 9. New treatment options for multidrug-resistant tuberculosis.
    Field SK, Fisher D, Jarand JM, Cowie RL.
    Ther Adv Respir Dis; 2012 Oct 30; 6(5):255-68. PubMed ID: 22763676
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M, Wan B, Zuliani V, Franzblau SG, Costantino G, Rivara M.
    Eur J Med Chem; 2015 Jul 15; 100():44-9. PubMed ID: 26071857
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH, Borges-Argáez R, Said-Fernández S, Vargas-Villarreal J, González-Salazar F, Méndez-González M, Cáceres-Farfán M, Molina-Salinas GM.
    Pulm Pharmacol Ther; 2014 Feb 15; 27(1):114-20. PubMed ID: 23968826
    [Abstract] [Full Text] [Related]

  • 18. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K.
    J Infect Dis; 2007 Aug 15; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [Abstract] [Full Text] [Related]

  • 19. Trends in discovery of new drugs for tuberculosis therapy.
    Riccardi G, Pasca MR.
    J Antibiot (Tokyo); 2014 Sep 15; 67(9):655-9. PubMed ID: 25095807
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.